ALGN vs STRO · P/E 35, rev $4.00B vs rev $62.0M
Align Technology Inc (ALGN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ALGN and STRO stock pages for the full models.
Not investment advice.